Antiarrhythmic drugs for atrial fibrillation in the outpatient setting

被引:0
|
作者
Tseng, Andrew S. [1 ]
Desimone, Christopher V. [1 ]
Kowlgi, Gurukripa N. [1 ]
机构
[1] Mayo Clin, Dept Cardiovas Med, Rochester, MN USA
关键词
Atrial fibrillation; Cardiac arrhythmias; Outpatients; DIRECT ORAL ANTICOAGULANTS; HEART-FAILURE; DIGOXIN; DRONEDARONE; CAFFEINE; RISK; METAANALYSIS; ASSOCIATION; ARRHYTHMIAS; DOFETILIDE;
D O I
10.23736/S0026-4806.23.08524-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With burgeoning evidence for early rhythm control in patients with atrial fibrillation (AF), the management of AF in the outpatient setting has become more challenging. The primary care clinician often serves as the frontline in the pharmacologic management of AF. Because of drug interactions and the risk of proarrhythmia, many clinicians remain hesitant about the initiation and chronic management of antiarrhythmic drug prescriptions. However, with the likely increased use of antiarrhythmics for early rhythm control, understanding and familiarity with these medications have likewise become more important, especially since patients with AF probably have other non-cardiac medical conditions that can impact their antiarrhythmic therapy. In this comprehensive review, we provide informative, high-yield cases and edifying references that will help primary care providers become comfortable handling various clinical scenarios.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 50 条
  • [31] Non-antiarrhythmic drugs to prevent atrial fibrillation
    Folkeringa, RJ
    Tieleman, RG
    Crijns, HJGM
    HEART RHYTHM, 2004, 1 (04) : 516 - 518
  • [32] Non-Antiarrhythmic Drugs to Prevent Atrial Fibrillation
    Concepción Moro
    Antonio Hernández-Madrid
    Roberto Matía
    American Journal of Cardiovascular Drugs, 2010, 10 : 165 - 173
  • [33] New Class III Antiarrhythmic Drugs for Treatment of Atrial Fibrillation
    Maykov, E. B.
    KARDIOLOGIYA, 2012, 52 (11) : 56 - 65
  • [34] Can Polymorphisms Predict Response to Antiarrhythmic Drugs in Atrial Fibrillation?
    Daubert, James P.
    Pitt, Geoffrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (06) : 546 - 547
  • [35] Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation
    Qin, Dingxin
    Leef, George
    Alam, Mian Bilal
    Rattan, Rohit
    Munir, Mohamad Bilal
    Patel, Divyang
    Khattak, Furcian
    Adelstein, Evan
    Jain, Sandeep K.
    Saba, Samir
    JOURNAL OF CARDIOLOGY, 2016, 67 (5-6) : 471 - 476
  • [36] Prevention of attacks of atrial fibrillation by amiodarone in outpatient setting
    Bart, BY
    Smirnova, OL
    Larin, VG
    Morosovskaya, LA
    KARDIOLOGIYA, 1997, 37 (03) : 33 - 36
  • [37] Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
    Hwang, Inseok
    Park, Je-Wook
    Kwon, Oh-Seok
    Lim, Byounghyun
    Hong, Myunghee
    Kim, Min
    Yu, Hee-Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Joung, Boyoung
    Lee, Moon-Hyoung
    Pak, Hui-Nam
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [38] New antiarrhythmic drugs for atrial fibrillation: Focus on dronedarone and vernakalant
    Camm, A. John
    Savelieva, Irina
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2008, 23 (01) : 7 - 14
  • [39] New antiarrhythmic drugs for atrial fibrillation: Focus on dronedarone and vernakalant
    A. John Camm
    Irina Savelieva
    Journal of Interventional Cardiac Electrophysiology, 2008, 23 : 7 - 14
  • [40] Antiarrhythmic Drugs in Atrial Fibrillation: Is There Still a Role for Rhythm Control?
    Rich, Michael W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (10) : 2006 - 2007